Squarepoint Ops »

Contineum Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Contineum Therapeutics shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.6M 150k 17.61

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Msci Brazil Etf Call Option (EWZ)
Tesla Motors Call Option (TSLA)
Pdd Holdings Sponsored Ads Call Option (PDD)

View all positions for Squarepoint Ops

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Johnson & Johnson
Perceptive Advisors
Versant Venture Management
Hillhouse Capital Advisors
Franklin Resources
Samsara BioCapital
Vanguard Group
Altium Capital Management
BlackRock
Baker Bros. Advisors
Casdin Capital
Geode Capital Management
Squarepoint Ops
Citadel Advisors

View all funds holding Contineum Therapeutics